Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
HORIBA Scientific Releases LabSpec 6.3 Software Update
Tuesday, August 12, 2014
Enhanced capabilities include full 3D volume display for Raman spectroscopy.

Optibrium Launches SentiraTM: New Software for Compound Data Visualisation
Monday, August 11, 2014
Powerful desktop application simplifies visualisation, interpretation and presentation of compound data.

IBM Expands High Performance Computing Capabilities in the Cloud
Thursday, July 31, 2014
New option for high performance computing (HPC) available from IBM

ArxLab Notebook Web-based Electronic Notebook
Thursday, July 31, 2014
Arxspan highlights their cloud-based ELN.

Core Informatics Releases Core ELN Chemistry Application on Platform for Science
Monday, July 28, 2014
Newly developed application is designed to help chemists document research activities and compound registration in the cloud.

IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud
Monday, July 28, 2014
IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud

MDxI Launches LabFile Data Resource
Friday, July 25, 2014
New standard for defining and targeting US clinical laboratory universe.

PAC Releases New Lab Instrument Data Integration Software, IRIS
Saturday, July 19, 2014
IRIS provides innovative results management and reporting software for PAC laboratory instruments.

New Software for Malvern’s NanoSight NTA Systems
Friday, July 18, 2014
NTA 3.0 from Malvern improves user experience and enhances performance.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 865
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv